Skip to main content
PRLBProto Labs, Inc.Buy Wait5.5·$75.14+5.31%
Buy WaitModerate Confidence
Investment thesis

Proto Labs has beaten earnings estimates in all 4 of the last 4 quarters with an average surprise of 26%, delivers 179% free cash flow conversion, and holds a perfect Piotroski F-Score of 9/9, but the stock has already reached analyst targets and falling volume (declining on-balance volume) signals waning buying interest.

Thesis pillars

  • Target Reached Negative AsymmetryStable
  • Strong Earnings Beat StreakStable
  • Exceptional Fcf Conversion QualityStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Proto Labs, Inc. (PRLB) Stock Analysis

Range Bound setup

Buy WaitVALUE-TRAP 2/5GrowthModerate Confidence

Industrials · Metal Fabrication

Earnings in 0 days (2026-07-31). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait for pullback to $61.79. Weak momentum; also recent C-suite change — blocks BUY_NOW at $75.14. Engine's entry $61.79 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Value-trap signals (2/5): Revenue declining (-5.1% YoY), Negative free cash flow.

Protolabs, Inc. is a digital manufacturing company producing custom prototype and low-volume production parts, via injection molding, CNC machining, 3D printing, and sheet metal fabrication, for over 300,000 customers including 95% of the Fortune 100. Customers order through an... Read more

$75.14-0.5% A.UpsideScore 5.5/10#7 of 11 Metal Fabrication
QualityF-score9 / 9FCF yield2.71%
Entry $61.79(support + ATR (held))Stop $56.06Target $80.07(resistance)A.R:R -0.1:1
Analyst target$88.00+17.1%3 analysts
$80.07our TP
$75.14price
$88.00mean
$91

Wait for pullback to $61.79. Weak momentum; also recent C-suite change — blocks BUY_NOW at $75.14. Engine's entry $61.79 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Value-trap signals (2/5): Revenue declining (-5.1% YoY), Negative free cash flow. Chart setup: RSI 52 mid-range, Bollinger mid-band. Earnings in 0 days. Wait until post-earnings. Score 5.5/10, moderate confidence.

Passes 4/8 gates (clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: aggressive.

10-K grounded · weekly refresh

About Proto Labs, Inc.

About Proto Labs, Inc.

Protolabs manufactures custom prototype and production parts across four processes, injection molding, CNC machining, 3D printing, and sheet metal fabrication, from nine owned factories in Minnesota, North Carolina, New Hampshire, the U.K., and Germany, backed by its Protolabs Network of outside manufacturing partners. The company employed 2,280 full-time workers as of December 31, 2025, 1,627 in the United States and 653 in Europe, with international sales contributing approximately 19% of 2025 revenue, down from 21% in each of the prior two years.

Protolabs earns revenue on a per-part, on-demand basis: customers upload 3D CAD files to its web platform, which generates an automated price quote and manufacturability feedback, and orders route either to an in-house factory or, through the 2021-acquired Protolabs Network, to a global roster of third-party manufacturing partners across North America, Europe, and Asia. Its top served industries are medical and healthcare, computer electronics, industrial machinery and equipment, aerospace, and automotive, and it competes against thousands of regional machine shops, injection molders, and 3D-printing bureaus, digital brokers offering similar manufacturer networks, and captive in-house manufacturing operations at large product developers. Research and development spending, aimed at expanding manufacturing processes and pricing/routing software, totaled $42.8 million in 2025, up from $41.3 million in 2024 and $40.1 million in 2023. In October 2024 the board approved closing the company's prototype injection-molding facility in Eschenlohe, Germany, and discontinuing metal 3D-printing services in Putzbrunn, Germany, substantially completed in the fourth quarter of 2025.

Show full overview

Protolabs' revenue is tied to customers' product-development budgets rather than steady-state production volume, an early-cycle exposure that showed up directly in 2025: the company closed its Eschenlohe, Germany injection-molding plant and discontinued Putzbrunn's metal 3D-printing line, completing the wind-down in the fourth quarter, while workforce attrition ran 13.6% in both the United States and Europe amid what the company describes as restructuring and transformation of the organization. Protolabs states it is redeploying the resulting cost savings into automation, core-systems, and digital-capability investments rather than into new facility capacity, a posture consistent with a company managing through softer prototype and low-volume demand rather than expanding to meet it.

See also: Industrials · Metal Fabrication

From Proto Labs, Inc.'s most recent 10-K filing, extracted July 6, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Fri, Jul 31, 2026today· next earnings call

Thesis

Rewards
No bull case signals
Risks
Analyst target reached - limited upside remaining
Value-trap signals (2/5): Revenue declining (-5.1% YoY), Negative free cash flow

Key Metrics

P/E (TTM)67.3
P/E (Fwd)32.3
Mkt Cap$1.7B
EV/EBITDA23.5
Profit Mgn4.7%
ROE3.8%
Rev Growth10.4%
Beta1.38
DividendNone
Rating analysts11

Quality Signals

Piotroski F9/9MoatNarrow

Options Flow

P/C0.50bullish
IV65%elevated

Concentration Risks(10-K Item 1A)

  • LOWGeographicinternational revenue19%
    10-K Item 1A: 'Our international revenue accounted for approximately 19%, 21% and 21% of our total revenue in each of the years ended December 31, 2025, 2024 and 2023, respectively.'

Material Events(8-K, last 90d)

  • 2026-05-07Item 5.02MEDIUM
    COO Michael Kenison announced plans to retire effective July 1, 2026, thanked for his service. Separately, Bernardo Parlange was appointed Chief Commercial Officer, a newly created role overseeing global commercial strategy, effective May 18, 2026. Clean, non-adversarial executive transition.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Obv
1.0
Volume
1.2
Ma Position
4.0
Rsi
5.5
Volume distribution (falling OBV)Above 200-day MA
GatesMomentum 2.3<4.5A.R:R -0.1=NEGATIVEEARNINGS PROXIMITY 0d<=7dExecutive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
52 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $71.01Resistance $81.70

Price Targets

$56
$62
$80
A.Upside-0.5%
A.R:R-0.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-0.5% upside)
! Earnings in 0 days - binary event risk
! momentum at 2.3 (below the engine's 4.5 threshold)

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-31 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PRLB stock a buy right now?

Wait for pullback to $61.79. Weak momentum; also recent C-suite change — blocks BUY_NOW at $75.14. Engine's entry $61.79 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Value-trap signals (2/5): Revenue declining (-5.1% YoY), Negative free cash flow. Chart setup: RSI 52 mid-range, Bollinger mid-band. Earnings in 0 days. Wait until post-earnings. Target $80.07 (+6.6%), stop $56.06 (−34.0%), A.R:R -0.1:1. Score 5.5/10, moderate confidence.

What is the PRLB stock price target?

Take-profit target: $80.07 (-0.5% upside). Target $80.07 (+6.6%), stop $56.06 (−34.0%), A.R:R -0.1:1. Stop-loss: $56.06.

What are the risks of investing in PRLB?

Analyst target reached - limited upside remaining; Value-trap signals (2/5): Revenue declining (-5.1% YoY), Negative free cash flow.

Is PRLB overvalued or undervalued?

Proto Labs, Inc. trades at a P/E of 67.3 (forward 32.3). TrendMatrix value score: 4.8/10. Verdict: Buy (Wait for Entry).

What do analysts say about PRLB?

11 analysts cover PRLB with a consensus score of 3.9/5. Average price target: $88.

What does Proto Labs, Inc. do?Protolabs, Inc. is a digital manufacturing company producing custom prototype and low-volume production parts, via...

Protolabs, Inc. is a digital manufacturing company producing custom prototype and low-volume production parts, via injection molding, CNC machining, 3D printing, and sheet metal fabrication, for over 300,000 customers including 95% of the Fortune 100. Customers order through an automated online quoting platform, and Protolabs fulfills parts through nine owned U.S. and European factories plus its Protolabs Network of third-party manufacturing partners; approximately 19% of 2025 revenue came from international sales.

Related stocks: MLI (Mueller Industries, Inc.) · CMC (Commercial Metals Company) · GPGI (GPGI, Inc.) · WOR (Worthington Enterprises, Inc.) · RYZ (Ryerson Holding Corporation)
Home Stocks PRLB

Latest news

Latest News

TradingKey2d ago
TradingKey2d ago
The Globe and Mail93d ago
TradingKey3d ago
Dars.gov.et23d agoEarnings
Marketscreener.com24d agoProduct
Marketscreener.com24d agoProduct
Investing.com Canada24d agoProduct
Marketscreener.com24d agoProduct
StockStory1d agoEarnings
TradingKey1d ago
StockStory92d agoEarnings
HarianBasis.co98d ago
Cổng thông tin điện tử tỉnh Lào Cai99d agoEarnings
Dars.gov.et25d agoEarnings
TradingKey5d ago
Kalkine Media97d ago
Yahoo Finance20d ago
Yahoo Finance20d agoProduct
Yahoo Finance20d agoProduct
Loading more...